Medscape7d
Impella LP2.5 vs. IABP in Cardiogenic SHOCK (ISAR-SHOCK)
The Impella group required transfusion of 2.6 U packed red blood cells versus 1.2 U in the IABP group (p = 0.18). Among patients with cardiogenic shock due to AMI, the Impella device resulted in a ...
GoodNewsNetwork4d
World’s Smallest Heart Pump ‘A Game-changer’ in Keeping Failing Hearts Going Without Major Surgery
For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.
TCTMD4y
Contemporary Look at the Treatment of Cardiogenic Shock with Impella
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Medscape8d
Cardiogenic Shock
Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...
Simple risk score model could help with weaning patients from mechanical circulatory support
Patients with severe heart failure or cardiogenic shock often require assistance from MCS devices such as venoarterial ...
Hosted on MSN1mon
FDA grants PMA approval to J&J MedTech’s heart pumps for paediatric use
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Johnson & Johnson (J&J) MedTech’s Impella 5.5 with SmartAssist and Impella CP with SmartAssist heart pumps ...